US Stocks

CGNX Stock Closes Up 0.64% on May 4, 2026 – Cognex Gains Momentum

Key Points

CGNX stock closed at $56.30, up 0.64% on May 4, 2026.

Meyka AI assigns B+ grade with 10 Buy analyst ratings supporting bullish outlook.

P/E of 82.82 reflects premium valuation justified by 64.68% operating cash flow growth.

Earnings announcement May 6 will test investor confidence in AI adoption and manufacturing demand.

Be the first to rate this article

Cognex Corporation (NASDAQ: CGNX) closed trading on May 4, 2026, with modest gains as the machine vision leader continues its strong year. CGNX stock finished at $56.30 USD, up 0.64% on the day with trading volume reaching 2.42 million shares. The company’s year-to-date performance stands at an impressive 56.48%, reflecting growing investor confidence in its automation and inspection technology platform. With earnings scheduled for May 6, market participants are closely watching CGNX stock for signals about manufacturing demand and AI-driven vision system adoption.

CGNX Stock Performance and Market Position

CGNX stock has delivered exceptional returns this year, trading between a 52-week low of $27.54 and a high of $59.88. The current price of $56.30 sits near the upper range, reflecting strong momentum in the machine vision sector. Over the past 12 months, CGNX stock has surged 101.14%, demonstrating the market’s appetite for automation technology.

Cognex maintains a market capitalization of $9.4 billion USD, positioning it as a significant player in industrial automation. The company’s 50-day moving average stands at $52.47, while the 200-day average sits at $44.22, both supporting the uptrend. Trading volume of 2.42 million shares slightly exceeded the 30-day average of 2.19 million, indicating healthy investor participation in CGNX stock.

Analyst Consensus and Meyka AI Grade for CGNX Stock

Wall Street remains bullish on CGNX stock with strong analyst backing. Out of 12 total ratings, 10 analysts rate CGNX as Buy, 1 rates it Strong Buy, and only 1 maintains a Hold position. This consensus score of 4.0 reflects overwhelming optimism about the company’s growth prospects. Meyka AI rates CGNX with a grade of B+, suggesting a buy recommendation based on comprehensive fundamental analysis.

This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The B+ rating indicates CGNX stock offers solid value despite elevated valuations. Meyka AI’s assessment reflects confidence in Cognex’s market position, though investors should note these grades are not guaranteed and we are not financial advisors.

Financial Metrics and Valuation of CGNX Stock

CGNX stock trades at a P/E ratio of 82.82, reflecting premium pricing typical of high-growth technology companies. The price-to-sales ratio stands at 9.48, indicating investors pay $9.48 for every dollar of revenue. While these multiples appear elevated, they align with the company’s strong earnings growth and market leadership in machine vision technology.

Key financial metrics show CGNX stock backed by solid fundamentals. Earnings per share reached $0.68, with free cash flow per share at $1.42. The company maintains a strong balance sheet with a current ratio of 3.80, indicating excellent short-term liquidity. Return on equity of 7.72% and operating cash flow growth of 64.68% demonstrate operational efficiency and cash generation capability. Track CGNX on Meyka for real-time updates on these key metrics.

Market Sentiment and Trading Activity for CGNX Stock

Market sentiment around CGNX stock remains constructive heading into earnings. The RSI indicator at 62.88 suggests the stock is approaching overbought territory but not yet extended. MACD momentum shows positive divergence with the histogram at 0.05, supporting continued upside potential for CGNX stock.

Trading activity reflects institutional interest in CGNX stock. Vanguard Group recently adjusted its position in the company, maintaining an 11.08% stake worth $668 million. The Money Flow Index at 56.03 indicates balanced buying and selling pressure. On-Balance Volume of 15.6 million shares shows accumulation patterns, suggesting institutional confidence in CGNX stock’s near-term direction.

Final Thoughts

Cognex Corporation maintains leadership in machine vision and automation with a B+ Meyka AI grade and strong analyst support. Despite elevated 82.82 P/E valuation, robust 64.68% operating cash flow growth and 101% one-year returns justify premium pricing. Investors should watch May 6 earnings for AI adoption and manufacturing demand insights. CGNX offers exposure to secular automation trends, though near-term consolidation is likely after the strong rally.

FAQs

What is the current price of CGNX stock?

CGNX closed at $56.30 USD on May 4, 2026, up 0.64% daily. The stock trades near its 52-week high of $59.88 and has gained 101.14% over 12 months, reflecting strong investor demand for machine vision technology.

What do analysts think about CGNX stock?

Wall Street is overwhelmingly bullish with 10 Buy, 1 Strong Buy, and 1 Hold rating. Consensus score of 4.0 reflects strong confidence. Meyka AI assigns a B+ grade, suggesting a buy based on fundamental analysis.

Is CGNX stock overvalued?

CGNX trades at elevated multiples: P/E of 82.82 and price-to-sales of 9.48. However, these reflect 64.68% operating cash flow growth and leadership in AI-driven machine vision, with B+ Meyka grade suggesting fair value.

When are Cognex earnings?

Cognex reports earnings on May 6, 2026, after market close, providing guidance on manufacturing demand, AI adoption rates, and future growth prospects.

What is Cognex Corporation’s business?

Cognex provides machine vision systems, software, and sensors automating manufacturing and distribution across consumer electronics, automotive, pharmaceuticals, and food industries.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)